Patent · US Active

Pyrrolotriazine compounds as TAM inhibitors

US10442810B2 · kind B2 · utility

11Cited by
3References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2018
Grant dateOct 15, 2019
Priority date—
Expiry dateMay 4, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.